CD40 ligand (CD40L) is a T cell surface molecule that is expressed early and transiently after cell activation. The interaction between CD40L and the B cell molecule CD40 has profound effects on B cell survival and function, on T cell priming and recall proliferation, and on monocyte activation and function. The importance of CD40/CD40L interaction is evident in the X-linked hyper IgM Syndrome (XHIM-1), which results from mutations in CD40L and is characterized by recurrent bacterial and opportunistic infections as well as malignant and autoimmune disease. XHIM-1 is an attractive candidate for gene therapy because of the accessability of the affected tissues and the evidence from maternal carriers that only partial reconstitution is required for normal function. CD40L surface expression is highly regulated, limited essentially to activated CD4+ T cells. It is subject to positive regulation by CD28 co-stimulation and to negative regulation by interferon gamma and TGF- beta. CD40L gene expression is dependent on the binding of a complex of the calcineurin-dependent nuclear factor of activated T cell (NF-AT) family members and activation protein-1 (AP-1) members in the CD40L promoter. Our preliminary data indicate that a second calcium/ calmodulin-dependent signal, mediated by CaM kinase IV/Gr, augments activity of the CD40L promoter. We propose to study the molecular mechanisms regulating CD40L gene expression by examining: I. Surface molecules that regulate CD40L expression: TCR/CD3, CD40L, CD28, IFNgamma, and TGF-beta using reporter gene assays, mRNA expression by Northern blot analysis, and by CD40L surface expression. II. The role of signaling pathways activated by T cell surface molecules in CD40L gene expression: calcium/calcineurin, CaM kinase IV/Gr, protein kinase C, Ras family members, STAT proteins, and octamer binding proteins. III. Identify the nuclear factors that are activated by the signaling pathways and that regulate CD40L gene transcription using electromobility gel shift and DNA footprinting assays. Definition of the regulation of CD40L gene expression should provide deeper understanding of T cell and B cell biology and may allow for the rational design of a construct for gene therapy of XHIM-1.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI001554-03
Application #
6168729
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
1998-08-01
Project End
2001-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
3
Fiscal Year
2000
Total Cost
$126,495
Indirect Cost
Name
Yale University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Mohapatra, Nrusingh P; Balagopal, Ashwin; Soni, Shilpa et al. (2007) AcpA is a Francisella acid phosphatase that affects intramacrophage survival and virulence. Infect Immun 75:390-6
Roux, Kenneth H; Taylor, Kenneth A (2007) AIDS virus envelope spike structure. Curr Opin Struct Biol 17:244-52
Balagopal, Ashwin; MacFarlane, Amanda Shearer; Mohapatra, Nrusingh et al. (2006) Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun 74:5114-25
Lobo, Francis M; Scholl, Paul R; Fuleihan, Ramsay L (2002) CD40 ligand-deficient T cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability. J Immunol 168:1473-8
Lobo, F M; Xu, S; Lee, C et al. (2000) Transcriptional activity of the distal CD40 ligand promoter. Biochem Biophys Res Commun 279:245-50
Lobo, F M; Zanjani, R; Ho, N et al. (1999) Calcium-dependent activation of TNF family gene expression by Ca2+/calmodulin kinase type IV/Gr and calcineurin. J Immunol 162:2057-63